Mortality trend from sporadic Creutzfeldt-Jakob disease (CJD) in Italy, 1993-2000

Journal of Clinical Epidemiology

Volumn 56, Issue 5, 2003, Pages 494-499

  Puopolo, Maria ^a   Ladogana, Anna ^a   Almonti, Susanna ^a   Daude, Nathalie ^a   Bevivino, Simona ^a   Petraroli, Rosella ^a,b   Poleggi, Anna ^a   Quanguo, Liu ^a   Pocchiari, Maurizio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Applera Italia   (Italy)

Author keywords

Creutzfeldt Jakob disease (CJD); Epidemiology; ; Molecular genetic; Mortality rate; Nation wide surveillance; Transmissible spongiform encephalopathy (TSE)

Indexed keywords

ADULT; AGED; ARTICLE; AWARENESS; CADAVER; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC PROCEDURE; EPIDEMIOLOGICAL DATA; FEMALE; GEOGRAPHY; GROUPS BY AGE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; PATIENT MONITORING; POPULATION RESEARCH; PRIORITY JOURNAL; REGISTER; SEX DIFFERENCE; SURVIVAL; TIME;

EID: 0037905552     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(02)00606-6     Document Type: Article

References (36)

1. Alperovitch A., Brown P., Weber T., Pocchiari M., Hofman A., Will R. Incidence of Creutzfeldt-Jakob disease in Europe in 1993. Lancet. 343:1994;918.
2. Delasnerie-Laupretre N., Poser S., Pocchiari M., Wientjens D.P., Will R. Creutzfeldt-Jakob disease in Europe. Lancet. 346:1995;898.
3. Will R.G., Alperovitch A., Poser S., Pocchiari M., Hofman A., Mitrova E., de Silva R., D'Alessandro M., Delasnerie-Laupretre N., Zerr I., van Duijn C. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for, CJD. Ann Neurol. 43:1998;763-767.
4. van Duijn C.M., Delasnerie-Laupretre N., Masullo C., Zerr I., de Silva R., Wientjens D.P., Brandel J.P., Weber T., Bonavita V., Zeidler M., Alperovitch A., Poser S., Granieri E., Hofman A., Will R.G. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD). Lancet. 351:1998;1081-1085.
5. Zerr I., Brandel J.P., Masullo C., Wientjens D., de Silva R., Zeidler M., Granieri E., Sampaolo S., van Duijn C., Delasnerie-Laupretre N., Will R., Poser S. European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors. J Clin Epidemiol. 53:2000;747-754.
6. Will R.G., Ironside J.W., Zeidler M., Cousens S.N., Estibeiro K., Alperovitch A., Poser S., Pocchiari M., Hofman A., Smith P.G. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 347:1996;921-925.
7. Bruce M.E., Will R.G., Ironside J.W., McConnell I., Drummond D., Suttie A., McCardle L., Chree A., Hope J., Birkett C., Cousens S., Fraser H., Bostock C.J. Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature. 389:1997;498-501.
8. Hill A.F., Desbruslais M., Joiner S., Sidle K.C., Gowland I., Collinge J., Doey L.J., Lantos P. The same prion strain causes vCJD and BSE. Nature. 389:1997;448-450.
9. Scott M.R., Will R., Ironside J., Nguyen H.O., Tremblay P., DeArmond S.J., Prusiner S.B. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci USA. 96:1999;15137-15142.
10. Lasmezas C.I., Fournier J.G., Nouvel V., Boe H., Marce D., Lamoury F., Kopp N., Hauw J.J., Ironside J., Bruce M., Dormont D., Deslys J.P. Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: implications for human health. Proc Natl Acad Sci USA. 98:2001;4142-4147.
11. Zerr I., Pocchiari M., Collins S., Brandel J.P., de Pedro Cuesta J., Knight R.S., Bernheimer H., Cardone F., Delasnerie-Laupretre N., Cuadrado Corrales N., Ladogana A., Bodemer M., Fletcher A., Awan T., Ruiz Bremon A., Budka H., Laplanche J.L., Will R.G., Poser S. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology. 55:2000;811-815.
12. World Health Organisation. The revision of the variant Creutzfeldt-Jakob (vCJD) case definition. Report of a WHO Consultation. Edinburgh, United Kingdom, 17 May 2001. 2001;WHO, Geneva. (WHO/CDS/CSR/EPH/2001.5).
13. Salvatore M., Genuardi M., Petraroli R., Masullo C., D'Alessandro M., Pocchiari M. Polymorphisms of the prion protein gene in Italian patients with Creutzfeldt-Jakob disease. Hum Genet. 94:1994;375-379.
14. Liddell F.D.K. Simple exact analysis of the standardised mortality ratio. J Epidemiol Community Health. 38:1984;85-88.
15. Hainfellner J.A., Jellinger K., Diringer H., Guentchev M., Kleinert R., Pilz P., Maier H., Budka H. Creutzfeldt-Jakob disease in Austria. J Neurol Neurosurg Psychiatry. 61:1996;139-142.
16. d'Aignaux J.H., Laplanche J.L., Delasnerie-Laupretre N., Brandel J.P., Peoc'h K., Salomon D., Hauw J.J., Alperovitch A. Trends in mortality from sporadic Creutzfeldt-Jakob disease in France 1992-7. J Neurol Neurosurg Psychiatry. 68:2000;787-789.
17. de Pedro Cuesta J. Futuro y problemática de la vigilancia de la enfermedad de Creutzfeldt-Jakob. Rev Neurol. 31:2000;167-170.
18. Cousens S.N., Zeidler M., Esmonde T.F., De Silva R., Wilesmith J.W., Smith P.G., Will R.G. Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96. BMJ. 315:1997;389-395.
19. National CJD Surveillance Unit. Ninth annual report 2000 - Creutzfeldt-Jakob disease surveillance in the UK. May 2001;NCJDSU, Edinburgh.
20. Nakamura Y., Yanagawa H., Hoshi K., Yoshino H., Urata J., Sato T. Incidence rate of Creutzfeldt-Jakob disease in Japan. Int J Epidemiol. 28:1999;130-134.
21. Gibbons R.V., Holman R.C., Belay E.D., Schonberger L.B. Creutzfeldt-Jakob disease in the United States: 1979-1998. JAMA. 284:2000;2322-2323.
22. Lundberg P.O. Creutzfeldt-Jakob disease in Sweden. J Neurol Neurosurg Psychiatry. 65:1998;836-841.
23. Cohen C.H. Does improvement in case ascertainment explain the increase in sporadic Creutzfeldt-Jakob disease since 1970 in the United Kingdom? Am J Epidemiol. 152:2000;474-479.
24. Wientjens D.P., Davanipour Z., Hofman A., Kondo K., Matthews W.B., Will R.G., van Duijn C.M. Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies. Neurology. 46:1996;1287-1291.
25. Brown P., Preece M., Brandel J.P., Sato T., McShane L., Zerr I., Fletcher A., Will R.G., Pocchiari M., Cashman N.R., d'Aignaux J.H., Cervenakova L., Fradkin J., Schonberger L.B., Collins S.J. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology. 55:2000;1075-1081.
26. Collins S., Law M.G., Fletcher A., Boyd A., Kaldor J., Masters C.L. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet. 353:1999;693-697.
27. Kondo K., Kuroiwa Y. A case control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol. 11:1982;377-381.
28. Davanipour Z., Alter M., Sobel E., Asher D., Gajdusek D.C. Creutzfeldt-Jakob disease: possible medical risk factors. Neurology. 35:1985;1483-1486.
29. Ward H.J.T., Everington D., Croes E.A., Alperovitch A., Delasnerie-Lauprêtre N., Zerr I., Poser S., van Duijn C.M. Sporadic Creutzfeldt-Jakob disease and surgery-a case control study using community controls. Neurology. 59:2002;543-548.
30. Arpino C., Conti S., Masocco M., Toccaceli V., Ladogana A., D'Alessandro M., Pocchiari M. Creutzfeldt-Jakob disease mortality in Italy, 1982-1996. Neuroepidemiology. 18:1999;92-100.
31. Alperovitch A., Zerr I., Pocchiari M., Mitrova E., de Pedro Cuesta J., Hegyi I., Collins S., Kretzschmar H., van Duijn C., Will R.G. Codon 129 prion proteins genotype and sporadic Creutzfeldt-Jakob disease. Lancet. 353:1999;1673-1674.
32. La Bella V., Collinge J., Pocchiari M., Piccoli F. Variant Creutzfeldt-Jakob disease in an Italian woman. Lancet. 360:2002;997-998.
33. Valleron A.J., Boelle P.Y., Will R., Cesbron J.Y. Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science. 294:2001;1726-1728.
34. Ferguson N.M., Ghani A.C., Donnelly C.A., Hagenaars T.J., Anderson R.M. Estimating the human health risk from possible BSE infection of the British sheep flock. Nature. 415:2002;420-424.
35. Brown P., Rodgers-Johnson P., Cathala F., Gibbs C.J. Jr., Gajdusek D.C. Creutzfeldt-Jakob disease of long duration: clinicopathological characteristics, transmissibility and differential diagnosis. Ann Neurol. 16:1984;295-304.
36. Raverdy P., Hauw J.J., Cathala F., Remy A., Brown P., Ernest A.M., Perie G. Maladie de Creutzfeldt-Jakob ayant évolué 34 mois chez une femme de 26 ans. Rev Neurol (Paris). 139:1983;381-383.